与中国药企“拉锯战”三年后,吉利德撤诉

健识局
27 Sep 2024

图源:网络经过三年时间的拉锯,吉利德在与国内药企凯因科技的专利战中撤诉。9月24日,凯因科技发布公告,吉利德撤回了上诉,一审判决生效。这起诉讼指的是2021年,吉利德曾起诉凯因科技,控诉其生产、制造、销售的索磷布韦片侵犯了自己的专利,要求凯因科技在2024年4月21日前停止侵权行为,并赔偿550万元。从结果来看,吉利德550万元的专利索赔要求是落空了。索磷布韦片是吉利德原研的丙肝“神药”,但由于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10